115 related articles for article (PubMed ID: 25371492)
1. Editorial commentary: persistent gonococcal DNA: artifact or real? Further insights into the biology of a remarkable pathogen.
Zenilman JM
Clin Infect Dis; 2015 Feb; 60(4):564-5. PubMed ID: 25371492
[No Abstract] [Full Text] [Related]
2. Persistence of Neisseria gonorrhoeae DNA following treatment for pharyngeal and rectal gonorrhea is influenced by antibiotic susceptibility and reinfection.
Bissessor M; Whiley DM; Fairley CK; Bradshaw CS; Lee DM; Snow AS; Lahra MM; Hocking JS; Chen MY
Clin Infect Dis; 2015 Feb; 60(4):557-63. PubMed ID: 25371490
[TBL] [Abstract][Full Text] [Related]
3. Single-Dose Zoliflodacin (ETX0914) for Treatment of Urogenital Gonorrhea.
Taylor SN; Marrazzo J; Batteiger BE; Hook EW; Seña AC; Long J; Wierzbicki MR; Kwak H; Johnson SM; Lawrence K; Mueller J
N Engl J Med; 2018 Nov; 379(19):1835-1845. PubMed ID: 30403954
[TBL] [Abstract][Full Text] [Related]
4. Azithromycin in the treatment of infection with Neisseria gonorrhoeae.
Bignell C; Garley J
Sex Transm Infect; 2010 Nov; 86(6):422-6. PubMed ID: 20940153
[TBL] [Abstract][Full Text] [Related]
5. Persistence after treatment of pharyngeal gonococcal infections in patients of the STI clinic, Amsterdam, the Netherlands, 2012-2015: a retrospective cohort study.
Hananta IPY; De Vries HJC; van Dam AP; van Rooijen MS; Soebono H; Schim van der Loeff MF
Sex Transm Infect; 2017 Nov; 93(7):467-471. PubMed ID: 28822976
[TBL] [Abstract][Full Text] [Related]
6. Spontaneous Clearance of Pharyngeal Gonococcal Infections: A Retrospective Study in Patients of the Sexually Transmitted Infections Clinic; Amsterdam, the Netherlands; 2012 to 2015.
Hananta IPY; de Vries HJC; van Dam AP; van Rooijen MS; Soebono H; Schim van der Loeff MF
Sex Transm Dis; 2018 Sep; 45(9):594-599. PubMed ID: 29465642
[TBL] [Abstract][Full Text] [Related]
7. Multiple doses of cefodizime are necessary for the treatment of Neisseria gonorrhoeae pharyngeal infection.
Matsumoto T; Muratani T; Takahashi K; Ikuyama T; Yokoo D; Ando Y; Sato Y; Kurashima M; Shimokawa H; Yanai S
J Infect Chemother; 2006 Jun; 12(3):145-7. PubMed ID: 16826347
[TBL] [Abstract][Full Text] [Related]
8. Retrospective review of pharyngeal gonorrhea treatment failures in Alberta, Canada.
Gratrix J; Bergman J; Egan C; Drews SJ; Read R; Singh AE
Sex Transm Dis; 2013 Nov; 40(11):877-9. PubMed ID: 24113412
[TBL] [Abstract][Full Text] [Related]
9. Perianal abscess due to Neisseria gonorrhoeae: an unusual case in the post-antibiotic era.
El-Dhuwaib Y; Ammori BJ
Eur J Clin Microbiol Infect Dis; 2003 Jul; 22(7):422-3. PubMed ID: 12827535
[TBL] [Abstract][Full Text] [Related]
10. Treatment of uncomplicated gonorrhea in women with single-dose cefonicid.
Handsfield HH; Murphy VL
Sex Transm Dis; 1985; 12(2):90-2. PubMed ID: 3923633
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Neisseria gonorrhoeae isolates from the genital tract and pharynx of two gonorrhea patients.
Saika T; Nishiyama T; Kanayama A; Kobayashi I; Nakayama H; Tanaka M; Naito S
J Infect Chemother; 2001 Sep; 7(3):175-9. PubMed ID: 11810580
[TBL] [Abstract][Full Text] [Related]
12. The outcome of oropharyngeal gonorrhoea treatment with different regimens.
Harry TC
Int J STD AIDS; 2005 Jul; 16(7):520. PubMed ID: 16004640
[No Abstract] [Full Text] [Related]
13. Testing for pharyngeal gonorrhoea in heterosexual men: should we revisit national guidelines?
Dresser M; Hussey J
Int J STD AIDS; 2020 May; 31(6):593-595. PubMed ID: 32295478
[No Abstract] [Full Text] [Related]
14. Treatment failure of pharyngeal gonorrhoea with internationally recommended first-line ceftriaxone verified in Slovenia, September 2011.
Unemo M; Golparian D; Potočnik M; Jeverica S
Euro Surveill; 2012 Jun; 17(25):. PubMed ID: 22748003
[TBL] [Abstract][Full Text] [Related]
15. Failure of 500 mg of ceftriaxone to eradicate pharyngeal gonorrhoea, Australia.
Y Chen M; Stevens K; Tideman R; Zaia A; Tomita T; Fairley CK; Lahra M; Whiley D; Hogg G
J Antimicrob Chemother; 2013 Jun; 68(6):1445-7. PubMed ID: 23390207
[No Abstract] [Full Text] [Related]
16. Do women need screening for extragenital gonococcal and chlamydial infections?
Dombrowski JC
Sex Transm Dis; 2015 May; 42(5):240-2. PubMed ID: 25868134
[No Abstract] [Full Text] [Related]
17. Two cases of failed ceftriaxone treatment in pharyngeal gonorrhoea verified by molecular microbiological methods.
Tapsall J; Read P; Carmody C; Bourne C; Ray S; Limnios A; Sloots T; Whiley D
J Med Microbiol; 2009 May; 58(Pt 5):683-687. PubMed ID: 19369534
[TBL] [Abstract][Full Text] [Related]
18. Incidence and treatment outcomes of pharyngeal Neisseria gonorrhoeae and Chlamydia trachomatis infections in men who have sex with men: a 13-year retrospective cohort study.
Ota KV; Fisman DN; Tamari IE; Smieja M; Ng LK; Jones KE; Diprima A; Richardson SE
Clin Infect Dis; 2009 May; 48(9):1237-43. PubMed ID: 19323630
[TBL] [Abstract][Full Text] [Related]
19. Oropharyngeal gonorrhoea: rate of co-infection with sexually transmitted infection, antibiotic susceptibility and treatment outcome.
Manavi K; Zafar F; Shahid H
Int J STD AIDS; 2010 Feb; 21(2):138-40. PubMed ID: 19884359
[TBL] [Abstract][Full Text] [Related]
20. Increased Detection of Pharyngeal and Rectal Gonorrhea in Men Who Have Sex With Men After Transition From Culture To Nucleic Acid Amplification Testing.
Cornelisse VJ; Chow EP; Huffam S; Fairley CK; Bissessor M; De Petra V; Howden BP; Denham I; Bradshaw CS; Williamson D; Chen MY
Sex Transm Dis; 2017 Feb; 44(2):114-117. PubMed ID: 27984552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
